Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Takeda Pharmaceutical Co. Ltd (TAK)

18.49   -0.06 (-0.32%) 08-14 16:00
Open: 18.53 Pre. Close: 18.55
High: 18.565 Low: 18.46
Volume: 498,001 Market Cap: 58,298M
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers medicines in various therapeutic areas, including gastroenterology; cancer; neurological and psychiatric diseases; and rare diseases, such as immunology and hematology, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.589 - 18.691 18.691 - 18.775
Low: 18.208 - 18.338 18.338 - 18.445
Close: 18.296 - 18.492 18.492 - 18.656

Technical analysis

as of: 2020-08-14 4:34:46 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 21.98     One year: 25.67
Support: Support1: 17.74    Support2: 17.08
Resistance: Resistance1: 18.82    Resistance2: 21.98
Pivot: 18.30
Moving Average: MA(5): 18.48     MA(20): 18.11
MA(100): 17.78     MA(250): 18.19
MACD: MACD(12,26): 0.17     Signal(9): 0.11
Stochastic oscillator: %K(14,3): 80.75     %D(3): 82.37
RSI: RSI(14): 57.40
52-week: High: 20.93  Low: 12.43  Change(%): 10.1
Average Vol(K): 3-Month: 108034  10-Days: 74262

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TAK has closed below upper band by 28.8%. Bollinger Bands are 59.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to TAK's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 07 Aug 2020
Is Takeda Pharmaceutical Co Ltd (TAK) The Right Choice in Drug Manufacturers - Specialty & Generic? - InvestorsObserver

Fri, 07 Aug 2020
Novavax and Takeda Announce Collaboration for Novavax' COVID-19 Vaccine Candidate in Japan - GlobeNewswire

Mon, 03 Aug 2020
AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments - MarketWatch

Mon, 03 Aug 2020
Takeda Pharmaceutical : Announcement of a merger (simple merger/short-form merger) with a wholly-owned subsidiary - Marketscreener.com

Sat, 01 Aug 2020
Edited Transcript of 4502.T earnings conference call or presentation 31-Jul-20 1:00pm GMT - Yahoo Finance

Fri, 31 Jul 2020
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for - PharmiWeb.com

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers Specialty & Generic
Shares Out. (M) 3,120
Shares Float (M) 3,000
% Held by Insiders
% Held by Institutions 4.23
Shares Short (K) 2,090
Shares Short P. Month (K) 2,120

Stock Financials

EPS 0.810
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 12.550
Profit Margin 1.34
Operating Margin
Return on Assets (ttm) 1.4
Return on Equity (ttm) 0.9
Qtrly Rev. Growth 7.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio 22.83
PEG Ratio 0.20
Price to Book value 1.47
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend 1.630
Forward Dividend 0.840
Dividend Yield 0.09
Dividend Pay Date 2009-12-14
Ex-Dividend Date 2020-03-29
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.